What is the initial treatment approach for a 14-year-old patient presenting to the Emergency Room (ER) with a migraine headache?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ER Treatment for Migraine in a 14-Year-Old

Start with ibuprofen 400-800 mg (weight-appropriate dosing) plus metoclopramide 10 mg IV as first-line therapy for acute migraine in adolescents presenting to the emergency room. 1

First-Line IV Treatment Protocol

For moderate to severe migraine in the ER setting:

  • Administer ibuprofen at weight-appropriate doses (typically 400-800 mg) as the American Academy of Neurology recommends this as first-line treatment for adolescents with migraine 1
  • Add metoclopramide 10 mg IV for both its antiemetic properties and direct analgesic effects through central dopamine receptor antagonism 2
  • Administer medication as early as possible during the attack to maximize efficacy—effectiveness depends critically on timing 1

Alternative first-line combination:

  • Ketorolac 30 mg IV plus metoclopramide 10 mg IV provides rapid pain relief with minimal rebound headache risk 2
  • Ketorolac has relatively rapid onset with approximately 6 hours duration, making it ideal for severe migraine abortive therapy 2

When First-Line Treatment Fails

If ibuprofen fails after 2-3 consecutive attacks or if the patient presents with severe, disabling migraine:

  • Escalate to triptans for moderate-to-severe migraine 1
  • Intranasal sumatriptan 5-20 mg is particularly effective when significant nausea or vomiting is present 1, 2
  • Rizatriptan is useful in adolescents as it comes in an absorbable wafer form, beneficial when nausea develops 1

Critical contraindications for triptans:

  • Do NOT use if the patient has uncontrolled hypertension, basilar or hemiplegic migraine, or cardiovascular risk factors 1

Adjunctive Nausea Management

If nausea or vomiting is prominent:

  • Domperidone can be used for nausea in adolescents aged 12-17 years, though oral administration is unlikely to prevent vomiting 1
  • Use a nonoral route of administration and add an antiemetic when nausea is significant 1
  • Metoclopramide is safe and effective for migraine-associated nausea in this age group 1

Alternative IV Options

If standard therapy is contraindicated or ineffective:

  • Prochlorperazine 10 mg IV effectively relieves headache pain and is comparable to metoclopramide in efficacy 2
  • Dihydroergotamine (DHE) intranasal or IV has good evidence for efficacy as monotherapy 2

Critical Medication Overuse Warning

Limit acute treatment to no more than 2 days per week to prevent medication-overuse headache, which paradoxically increases headache frequency and can lead to daily chronic headaches 1

Red Flags Requiring Neuroimaging

Obtain neuroimaging if any of the following are present:

  • Headache worsened by Valsalva maneuver 1
  • Headache that awakens from sleep 1
  • Progressive worsening pattern 1
  • Abnormal neurologic examination findings 1

Disposition and Follow-Up Planning

Before discharge:

  • Evaluate for preventive treatment if the patient has ≥2 migraine attacks per month causing disability for 3+ days, or uses rescue medication more than twice weekly 1
  • Propranolol is the first-line preventive medication with the best safety data in children and adolescents 1
  • Provide a headache diary to monitor frequency for 8-12 weeks when assessing treatment response 1

Common Pitfalls to Avoid

Do not allow frequent use of acute medications in response to persistent headaches—this creates medication-overuse headache 1

Bed-rest alone might suffice in children with short-duration attacks, so avoid unnecessary medication exposure when possible 1

Avoid opioids completely as they can lead to dependency, rebound headaches, and eventual loss of efficacy 2

Family members and teachers should be educated about the condition and management plan, as active help from both is usually necessary 1

References

Guideline

Management of Non-Intractable Migraine in Adolescents

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the evaluation and treatment steps for migraines with identified red flags?
What are the potential causes and management options for a 30-year-old female with intractable migraines lasting 5 days, worsening with positional changes, and unresponsive to oral or intravenous (IV) medications, with a normal computed tomography (CT) scan?
What is the appropriate management for a 15-year-old with headaches?
What are the first-line preventive medications for patients with more than 18 migraines per month?
What is the treatment for headache (HA) lasting over 24 hours with associated sinus pressure?
What are the recommendations for a patient with a Body Mass Index (BMI) less than 22 who is taking Glucagon-Like Peptide-1 (GLP-1) receptor agonists, such as semaglutide (GLP-1 receptor agonist) or tirzepatide (GLP-1 and glucose-dependent insulinotropic polypeptide receptor agonist), for weight loss?
Should a GLP-1 (Glucagon-like peptide-1) receptor agonist, such as semaglutide (generic name) or tirzepatide (generic name), be continued or discontinued in a patient who has achieved a BMI reduction from 30 to 22?
What are the Beers criteria for potentially inappropriate medication use in older adults?
What is the preferred choice between Semaglutide (Ozempic) and Mounjaro (Tirzepatide) for a patient with type 2 diabetes?
What is the optimal medication management plan for a 78-year-old patient with hypertension (controlled), type 2 diabetes (A1c 7.8%), mild knee osteoarthritis, early cataracts, and frailty, currently taking amlodipine, metformin, simvastatin, paracetamol (as needed), vitamin B12 supplement (without documented deficiency), and trimetazidine (without history of angina), presenting with unintentional weight loss, postural hypotension, and reduced mobility?
Can a patient using Glucerna (diabetic nutritional supplement) be substituted with Jevity 1.2 (tube feeding formula) due to unavailability of Glucerna?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.